Rizwan Khan

Rizwan Khan is a Global Study Associate Director at AstraZeneca, leveraging over 15 years of experience in clinical trial management across four countries. With a Master's degree in Pharmacology and an MBA from The University of Hong Kong, Rizwan has successfully led cross-functional study teams, implementing innovative solutions and managing complex global studies in various therapeutic areas. Their project management expertise includes significant achievements at Eli Lilly, where they contributed to the registration of multiple pharmaceutical products. Rizwan is recognized for driving effective change and collaboration within study teams, ensuring operational excellence in clinical research.